The Rapid Plasma Reagin Test Market is expected to register a CAGR of 4% during the forecast period 2022-2028. The Rapid Plasma Reagin (RPR) test is clinically recognized worldwide as a non-specific serological test for syphilis, a sexually transmitted disease. They are further supplemented by a treponema test (TPHA). Increasing cases of recurrent syphilis in […]
